<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>PREVALENCE, DRUG PRESCRIPTION PATTERNS, CLINICAL FINDINGS IN CANINE GASTROENTERITIS AND GENETIC ANALYSIS OF CANINE PARVOVIRUS ISOLATES IN NIGERIA</title>
<link>http://hdl.handle.net/123456789/1330</link>
<description/>
<pubDate>Thu, 16 Apr 2026 01:33:38 GMT</pubDate>
<dc:date>2026-04-16T01:33:38Z</dc:date>
<item>
<title>PREVALENCE, DRUG PRESCRIPTION PATTERNS, CLINICAL FINDINGS IN CANINE GASTROENTERITIS AND GENETIC ANALYSIS OF CANINE PARVOVIRUS ISOLATES IN NIGERIA</title>
<link>http://hdl.handle.net/123456789/1331</link>
<description>PREVALENCE, DRUG PRESCRIPTION PATTERNS, CLINICAL FINDINGS IN CANINE GASTROENTERITIS AND GENETIC ANALYSIS OF CANINE PARVOVIRUS ISOLATES IN NIGERIA
SHIMA, FELIX KUNDU
Gastroenteritis is a frequent presentation in canine practice with challenges in its diagnosis and &#13;
management. Canine Parvovirus (CPV) is a common cause of gastroenteritis, mortality, and &#13;
economic losses with recurrent vaccination failure. Due to limited documented information on the &#13;
condition in Nigeria, this study was designed to investigate the prevalence, aetiologies, clinical &#13;
presentation, and management of canine gastroenteritis, and characterise CPV isolates in Nigeria.&#13;
Retrospective data of 3,882 dogs presented to ten veterinary clinics from seven locations &#13;
(Abeokuta, Abuja, Ibadan, Jos, Makurdi, Onitsha and Warri) in Nigeria from January to December &#13;
2016 were analysed for prevalence and drug prescription patterns for gastroenteritis. Also, 157 &#13;
cases of gastroenteritis were prospectively evaluated for their aetiologies and usefulness of clinical &#13;
pathology in prognostication using standard procedures. Electrocardiograms of 40 dogs with &#13;
confirmed Canine Parvovirus Enteritis (CPE) using rapid in-clinic assay kit and polymerase chain &#13;
reaction were evaluated for cardiac involvements. Protocols of CPV vaccination failure (94/157) &#13;
were examined for appropriateness. Polymerase chain reaction was done on the vaccine and &#13;
positive clinical samples using primers specific for parvoviral DNA and subjected to sequencing &#13;
and phylogenetic analysis. Data were analysed using descriptive statistics, Chi-square, and logistic &#13;
regression at α0.05.&#13;
Prevalence of gastroenteritis was 41.2% and was influenced by dog breed (α=0.014), vaccination &#13;
status (α=0.047) and period of the year (α=0.03). Polypharmacy was high with an average of 5.4 &#13;
drugs prescribed in each treatment regimen. Antibacterials (48.3%) and antiparasitics (23.8%) &#13;
were extensively prescribed. Canine parvovirus (92.9%), gastrointestinal parasites (12.1%), &#13;
coronavirus (2.6%), liver disease (0.6%) and undetermined causes (1.9%) were identified as the &#13;
aetiologies of the clinical cases. Colic (Odds Ratios [OR]=0.01; α=0.001), leukopaenia (OR=3.5, &#13;
α=0.01), hypoalbuminaemia (OR=7.1; α=0.006) and pancytopaenia (OR=0.2; α=0.002) at initial &#13;
time of presentation were prognostic for prolonged duration of management and poor outcomes. &#13;
Electrocardiographic changes comprising ST-depression (7.5%), tall T-wave (27.5%), S-wave &#13;
deepening (20.0%), prolonged QT-duration (25.0%), prolonged P-wave duration (17.5%), and &#13;
tachycardia (15.0%) were seen in 70.0% of confirmed CPE cases. Vaccination failure was &#13;
associated with the protocol adopted, with one-, two-, three- and four-dose protocols having failure &#13;
rates of 51.1%, 28.7%, 19.1% and 1.1%, respectively. Sequence and phylogenetic analysis of 11 &#13;
clinical samples showed that CPV-2c (63.6%) and CPV-2a (36.4%) were the predominant strains &#13;
and were genetically closely related to Asian and European strains. Amino acid changes (T301S, &#13;
D305Y, Y323I, Q370R, T440A, Y444S and I447M) were observed in the VP2 protein of the &#13;
clinical isolates. The vaccines that were sequenced contained CPV-2a only.&#13;
Canine parvovirus and gastrointestinal parasites were the leading causes of canine gastroenteritis &#13;
in Nigeria. Prescription patterns used in managing several cases were injudicious. Presentation &#13;
with colic, hypoalbuminaemia and leukopaenia are useful indicators for poor prognosis and &#13;
prolonged management. Assessment of cardiac functions in canine parvovirus enteritis is &#13;
recommended. Inappropriate vaccination protocols, viral mutations, and incorporation of only &#13;
CPV-2a strain in vaccines licensed for vaccinating dogs against canine parvovirus portends risk of &#13;
vaccination failure.
</description>
<pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/123456789/1331</guid>
<dc:date>2021-02-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
